GLP-1 receptor agonists for type 2 diabetes

Lancet. 2009 Jul 4;374(9683):4-6. doi: 10.1016/S0140-6736(09)60942-9. Epub 2009 Jun 8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Exenatide
  • Glucagon-Like Peptide 1 / agonists
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Glucagon-Like Peptide 1 / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Liraglutide
  • Multicenter Studies as Topic
  • Peptides / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Safety
  • Treatment Outcome
  • Venoms / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Peptides
  • Venoms
  • Liraglutide
  • Glucagon-Like Peptide 1
  • Exenatide